Jaime Garcia-Juarez

Dr. Jaime Garcia-Juarez


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 December 2015 in Medical Mycology
Verified
Journal Article
Closed access
PDF file
Rogelio de J. Treviño-RangelRogelio de J. Treviño-Rangel
Rogelio de J. Treviño-Rangel
HVHiram Villanueva-Lozano
Hiram Villanueva-Lozano
PHPedro Hernández-Rodríguez
Pedro Hernández-Rodríguez
MMMichel F. Martínez-Reséndez
Michel F. Martínez-Reséndez
JGJaime Garcia-Juarez
Jaime Garcia-Juarez
GGGloria M. González
Gloria M. González
Cryptococcus neoformans infection is an important cause of meningitis in HIV/AIDS endemic regions. Antifungals for its management include amphotericin B, flucytosine, and fluconazole. Recently, treatment of this mycosis with sertraline has been studied with variable clinical outcomes. The aim of the study was to assess the in vitro antifungal effect of sertraline against clinical isolates of Cryptococcus spp. as well as its in vivo activity in a murine model of cryptococcal meningoencephalitis. The in vitro susceptibility to fluconazole, amphotericin B, voriconazole and sertraline of 153 Cryptococcus spp. strains were evaluated according to CLSI procedures. Fungal tissue burden, serum antigenaemia and histopathology, together with the therapeutic efficacy of amphotericin B (3 mg/kg), fluconazole (15 mg/kg), and sertraline (3, 10, and 15 mg/kg) were evaluated in mice intracranially inoculated with one isolate of Cryptococcus neoformans. All strains were susceptible to the antifungals studied and exhibited growth inhibition with sertraline at clinically relevant concentrations. Sertraline at a dose of 15 mg/kg reduced the fungal burden in the brain and spleen with an efficacy comparable to that of fluconazole. In conclusion, sertraline exhibited an excellent in vitro-in vivo anti-cryptococcal activity, representing a possible new alternative for the clinical management of meningeal cryptococcosis.

13 May 2016 in Surgical and Radiologic Anatomy
Verified
Journal Article
Closed access
PDF file
RMRodolfo Morales-Avalos
Rodolfo Morales-Avalos
ASAdolfo Soto-Domínguez
Adolfo Soto-Domínguez
JGJaime Garcia-Juarez
Jaime Garcia-Juarez
OSOdila Saucedo-Cardenas
Odila Saucedo-Cardenas
JBJosé R. Bonilla-Galvan
José R. Bonilla-Galvan
RERodrigo Enrique Elizondo-Omaña
Rodrigo Enrique Elizondo-Omaña

23 January 2017 in Oncology Letters
Verified
Journal Article
Open access
PDF file
JPJose J. Perez-Trujillo
Jose J. Perez-Trujillo
RGRodolfo Garza-Morales
Rodolfo Garza-Morales
JBJose A. Barron-Cantu
Jose A. Barron-Cantu
GFGabriel Figueroa-Parra
Gabriel Figueroa-Parra
AGAracely Garcia-Garcia
Aracely Garcia-Garcia
MLMaria Loera-Arias
Maria Loera-Arias
Cellular immune responses play a critical role in the eradication of intracellular infections and malignant cells through the recognition and subsequent removal of the infection or malignant cells. Effective antigen presentation is crucial for stimulating the immune system against malignant cells. Calreticulin (CRT) has been used to improve antigen presentation. However, CRT overexpression has been previously associated with the development of pancreatic and breast cancer. The import and retention signals of CRT in the endoplasmic reticulum (ER) can be used to overcome CRT overexpression. The present study describes the potent antitumor effect of a DNA vaccine encoding human papillomavirus type 16 E6 and E7 antigens flanked by ER import and retention signals (SP‑E6E7m‑KDEL). The effect of this vaccine was compared with that of E6 and E7 antigens fused to human full‑length CRT (hCRT‑E6E7m). In the present study, the effectiveness of SP‑E6E7m‑KDEL for inducing an interferon‑γ antigen‑specific, response and its therapeutic effect against tumors was demonstrated, which was as effective as immunization against those antigens fused to CRT. This simplified strategy, using ER import and retention signal peptides to direct antigens to this organelle, provides an efficient alternative to traditional vaccines and, more importantly, a safe and potent system to induce a therapeutic antitumor response.

1 December 2013 in International Journal of Morphology
Verified
Journal Article
Open access
PDF file
RGRubén García Garza
Rubén García Garza
MLMartha E Salazar Leal
Martha E Salazar Leal
VDViktor Romero Díaz
Viktor Romero Díaz
JGJaime Garcia-Juarez
Jaime Garcia-Juarez
ADAdolfo Soto Domínguez
Adolfo Soto Domínguez
JSJulio Sepúlveda Saavedra
Julio Sepúlveda Saavedra

23 April 2015 in Medical Mycology
Verified
Journal Article
Closed access
PDF file
Rogelio de J. Treviño-RangelRogelio de J. Treviño-Rangel
Rogelio de J. Treviño-Rangel
GGGloria M. González
Gloria M. González
AMAzalia M. Martínez-Castilla
Azalia M. Martínez-Castilla
JGJaime Garcia-Juarez
Jaime Garcia-Juarez
EREfren Robledo-Leal
Efren Robledo-Leal
ARAdrian G. Rosas-Taraco
Adrian G. Rosas-Taraco
Despite the increasing incidence of the Candida parapsilosis complex in the clinical setting and high mortality rates associated with disseminated infection, the host-fungus interactions regarding Candida parapsilosis sensu stricto and the closely related species C. orthopsilosis and C. metapsilosis remains blurred. In this study, we analyzed inflammatory cytokines levels and histopathology as well as fungal burden in spleen, kidney and lung of mice infected with six strains of the “psilosis” group with different enzymatic profiles. Strong interleukin 22 (IL-22) and tumor necrosis factor α (TNF-α) responses were observed in analyzed organs from infected mice (P < .0001) regardless of the species and enzymatic profile. TNF-α and IL-22 levels were related with spleen inflammation and fungal load. Fungal cells were detected only in spleen and kidney of infected mice, especially by day 2 post-challenge. The kidney showed glomerular retraction and partial destruction of renal tubules. Our data suggest that a strong inflammatory response, mainly of IL-22 and TNF-α, could be involved in Candida parapsilosis complex infection control.

29 May 2018 in Lipids in Health and Disease
Verified
Journal Article
Open access
PDF file
ACAlberto Camacho
Alberto Camacho
JSJuan Carlos Segoviano
Juan Carlos Segoviano
ASAdriana Sánchez-Garcia
Adriana Sánchez-Garcia
JRJose de Jesus Herrera-De la Rosa
Jose de Jesus Herrera-De la Rosa
JGJaime Garcia-Juarez
Jaime Garcia-Juarez
RORocio Ortiz-Lopez
Rocio Ortiz-Lopez
Excessive subcutaneous adiposity in obesity is associated to positive white adipocyte tissue (WAT) differentiation (adipogenesis) and WAT expandability. Here, we hypothesized that supplementation with the insulin inhibitor and mitochondrial uncoupler, Tyrphostin (T-AG17), in vitro and in vivo inhibits adipogenesis and adipocyte hypertrophy. We used a 3T3-L1 proadipocyte cell line to identify the potential effect of T-AG17 on adipocyte differentiation and fat accumulation in vitro. We evaluated the safety of T-AG17 and its effects on physiological and molecular metabolic parameters including hormonal profile, glucose levels, adipogenesis and adipocyte hypertrophy in a diet-induced obesity model using C57BL/6 mice. We found that T-AG17 is effective in preventing adipogenesis and lipid synthesis in the 3T3-L1 cell line, as evidenced by a significant decrease in oil red staining (p < 0.05). In obese C57BL/6 mice, oral administration of T-AG17 (0.175 mg/kg for 2 weeks) lead to decreased fat accumulation and WAT hypertrophy. Further, T-AG17 induced adipocyte apoptosis by activating caspase-3. In the hepatocytes of obese mice, T-AG17 promoted an increase in the size of lipid inclusions, which was accompanied by glycogen accumulation. T-AG17 did not alter serum biochemistry, including glucose, insulin, leptin, free fatty acids, creatinine, and aspartate aminotransferase. T-AG17 promotes adipocyte apoptosis in vivo and is an effective modulator of adipocyte differentiation and WAT hypertrophy in vitro and in vivo. Therefore, T-AG17 may be useful as a pharmacological obesity treatment.